title: Cancer preventive agents 10. Prenylated dehydrozingerone analogs as potent chemopreventive agents.
abstract: Dehydrozingerone analogs and related compounds were screened as potential antitumor promoters by using the in vitro short-term 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced Epstein-Barr virus early antigen activation assay. Among the 40 synthesized compounds, the prenylated analogs 16 and 34-36 showed the most significant and promising activity (100% inhibition of activation at 1 x 10(3) mol ratio/TPA, and 82-80%, 37-35%, and 13-11% inhibition at 5 x 10(2), 1 x 10(2), and 1 x 10 mol ratio/TPA, respectively) in this screening. Their activity profiles were comparable to those of the reference standard curcumin. While a prenyl moiety conferred potent chemopreventive activity, an extended prenyl unit such as a farnesyl moiety did not improve activity. Because in vitro inhibitory effects in this assay generally correlate well with in vivo inhibitory effects on tumor promotion, our results strongly suggested that prenylated 16 and 34-36 are likely to be promising antitumor promoters.
authors.affiliation: Natural Products Research Laboratories, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, USA.
authors.forename: Jin
authors.initials: J
authors.lastname: Tatsuzaki
authors.forename: Kyoko
authors.initials: K
authors.lastname: Nakagawa-Goto
authors.forename: Harukuni
authors.initials: H
authors.lastname: Tokuda
authors.forename: Kuo-Hsiung
authors.initials: KH
authors.lastname: Lee
mesh_terms: D016588:Anticarcinogenic Agents / Q000737:chemistry* / Q000494:pharmacology*; D000956:Antigens, Viral / Q000187:drug effects*; D002273:Carcinogens / Q000494:pharmacology; D020650:Combinatorial Chemistry Techniques; D003474:Curcumin / Q000494:pharmacology; D015394:Molecular Structure; D013237:Stereoisomerism; D013343:Styrenes / Q000138:chemical synthesis* / Q000737:chemistry / Q000494:pharmacology*; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology*
chemical_list: D016588:Anticarcinogenic Agents; D000956:Antigens, Viral; D002273:Carcinogens; C033305:Epstein-Barr virus early antigen; D013343:Styrenes; C052933:methyl-3-methoxy-4-hydroxystyryl ketone; D003474:Curcumin; D013755:Tetradecanoylphorbol Acetate
references.citation: J Bacteriol. 1966 Mar;91(3):1248-56
references.pmid: 4160230
references.citation: Bioorg Med Chem. 2003 Mar 20;11(6):1137-40
references.pmid: 12614901
references.citation: Chem Pharm Bull (Tokyo). 1990 Oct;38(10):2737-9
references.pmid: 1963812
references.citation: Bioorg Med Chem. 2002 Oct;10(10):3361-5
references.pmid: 12150883
references.citation: Biol Pharm Bull. 1994 May;17(5):668-71
references.pmid: 7920430
references.citation: J Nat Prod. 2003 Feb;66(2):200-5
references.pmid: 12608849
references.citation: J Nat Prod. 2000 Oct;63(10):1344-8
references.pmid: 11076549
references.citation: Cancer Lett. 2004 Oct 28;214(2):165-9
references.pmid: 15363542
references.citation: J Nat Prod. 2004 Jul;67(7):1125-30
references.pmid: 15270565
references.citation: Cancer Lett. 1999 Jul 19;142(1):49-54
references.pmid: 10424780
references.citation: Cancer Lett. 2003 Nov 25;201(2):133-7
references.pmid: 14607326
references.citation: Cancer Lett. 2000 Oct 31;159(2):135-40
references.pmid: 10996724
references.citation: Cancer Lett. 1995 Jul 20;94(1):79-83
references.pmid: 7621448
references.citation: Cancer Lett. 2003 Apr 25;193(2):133-8
references.pmid: 12706869
references.citation: Cancer Lett. 1986 Dec;33(3):279-85
references.pmid: 3802058
references.citation: Cancer Res. 1988 Nov 1;48(21):5941-6
references.pmid: 3139287
references.citation: J Nat Prod. 2003 Feb;66(2):206-9
references.pmid: 12608850
references.citation: Biochem Pharmacol. 1996 Aug 23;52(4):519-25
references.pmid: 8759023
references.citation: Cancer Lett. 1998 Dec 11;134(1):37-42
references.pmid: 10381128
references.citation: J Nat Prod. 2006 Oct;69(10):1445-9
references.pmid: 17067159